The objective of this study is to obtain data on the technical feasibility, safety, and efficacy of the second-generation eCLIPs products for the treatment of bifurcation aneurysms. VANCOUVER, British Columbia–(BUSINESS WIRE)–Evasc Neurovascular, a pioneer in the development of disruptive endovascular treatments for cerebral aneurysms, announced today the enrollment of the […]

VANCOUVER, British Columbia–(BUSINESS WIRE)–Evasc Neurovascular is proud to announce the third generation of its eCLIPs™ device, the eCLIPs Bifurcation Flow Diverter. The new device is classified as a flow diverter, with a leaf density of 35%, which is 60% higher than the existing eCLIPs devices. As a result, the new […]